Pharmacokinetic and Toxicokinetic Analysis
We have many years of experience carrying out pharmacokinetic (PK) and toxicokinetic (TK) analysis for all stages of drug development, providing expertise, flexibility and quality to our clients.
Support for preclinical and clinical studies
Our trained and experienced pharmacokineticists use industry standard Phoenix WinNonLin® for non-compartmental analysis, giving you access to a complete bioanalytical and pharmacokinetic/toxicokinetic (PK/TK) service to support your preclinical and clinical studies.
We provide high quality tables, figures and listings along with interpretation, while comprehensive SOPs and Quality Assurance facilities ensure regulatory compliance.
We offer a standalone service in which we perform PK/TK analysis on data generated outside of LGC. This will be project managed within the pharmacokinetics team, as a discrete study phase or project.
We can provide data in bespoke formats to meet your exact reporting needs with expert advice and interpretation. LGC’s dedicated data management team allows us to provide data transfers and reporting to Clinical Data Interchange Standards Consortium (CDISC) specifications for the Exchange of Nonclinical Data (SEND) and Human Clinical Data (SDTM).